Literature DB >> 7471209

Adenovirus early gene products may control viral mRNA accumulation and translation in vivo.

H Persson, H J Monstein, G Akusjärvi, L Philipson.   

Abstract

The mechanisms controlling early adenovirus gene expression in vivo have been studied using inhibitors of protein synthesis. When inhibitors were added shortly before or at the onset of infection, viral mRNA from all early regions was transcribed, spliced and accumulated over a 7 hr period. After longer pretreatment, accumulation of several early mRNAs were suppressed. Addition of inhibitors 1 hr after infection enhanced the accumulation of viral mRNA in the cytoplasm. Translation of early mRNA selected on adenovirus DNA in a cell-free system reflected the amount of viral mRNA present. A viral coded product may therefore control accumulation of viral mRNA. A different pattern emerged when inhibitors of protein synthesis were removed at 5 hr postinfection and cells were removed at 5 hr postinfection and cells were pulse-labeled in vivo. If inhibitors were introduced at or before infection, early viral proteins were synthesized only after a lag of 1-3 hr. However, if treatment was introduced 1 hr postinfection, reversion of the protein synthesis block was instantaneous. It appears that protein synthesis inhibitors reveal an in vivo translational block for viral mRNA. This block could be overcome by preinfection with a related virus. Furthermore, no block was observed in a virus-transformed human embryonic kidney cell line (293) which expresses early region 1 of the viral genome. Viral gene product(s) encoded in early region 1 may control translation of early adenovirus messenger RNA in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7471209     DOI: 10.1016/0092-8674(81)90144-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products.

Authors:  M G Katze; H Persson; L Philipson
Journal:  Mol Cell Biol       Date:  1981-09       Impact factor: 4.272

2.  Selective inhibition of adenovirus type 2 early region II and III transcription by an anisomycin block of protein synthesis.

Authors:  A R Shaw; E B Ziff
Journal:  Mol Cell Biol       Date:  1982-07       Impact factor: 4.272

3.  An insertion mutation in the adenovirus type 12 early region 1A 13S mRNA unique region.

Authors:  K Ohshima; K Shiroki
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

Review 4.  The structure and functions of the adenovirus early region 1 proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

5.  The interplay between host and viral genes in adenovirus gene expression.

Authors:  L Philipson
Journal:  Klin Wochenschr       Date:  1984-05-15

6.  Transcription of adenovirus cores in vitro: major RNA products differ from those made from a DNA template.

Authors:  E Daniell; M J Fedor
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Expression of adenovirus type 12 E1A gene in monkey cells, using a simian virus 40 vector.

Authors:  K Oda; H Kato; I Saito; S Sugano; K Maruyama; M Masuda; K Shiroki; H Shimojo
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

8.  Transformation of rodent cells by DNA extracted from transformation-defective adenovirus mutants.

Authors:  D T Rowe; F L Graham
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

9.  Activation of early adenovirus transcription by the herpesvirus immediate early gene: evidence for a common cellular control factor.

Authors:  L T Feldman; M J Imperiale; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.

Authors:  D L Weeks; N C Jones
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.